[Elsevier] Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

wnw233 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-19 12:13
Reward10points

journalㄩJournal of Hepatology

AuthorsㄩNaim Alkhouri; Robert Herring; Heidi Kabler; Zeid Kayali; Tarek Hassanein; Anita Kohli; Ryan S. Huss; Yanni Zhu; Andrew N. Billin; Lars Holm Damgaard; Kristine Buchholtz; Mette Skalshi Kjr; Clare Balendran; Robert P. Myers; Rohit Loomba; Mazen Noureddin

Published dateㄩ2022-9-

DOIㄩ10.1016/j.jhep.2022.04.003

PDF linkㄩhttps://www.sciencedirect.com/sc ... 168827822002355/pdf

Article linkㄩhttps://doi.org/10.1016/j.jhep.2022.04.003

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
elinasiri Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    40


Return to the list